Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Transmedics Group Inc shares valued at $95,903 were sold by Ranganath Anil P. on Jun 09 ’25. At $139.80 per share, Ranganath Anil P. sold 686 shares. The insider’s holdings dropped to 13,955 shares worth approximately $1.74 million following the completion of this transaction.
Also, Basile Edward M sold 5,000 shares, netting a total of over 632,250 in proceeds. Following the sale of shares at $126.45 each, the insider now holds 2,866 shares.
Before that, EDWARD BASILE had added 5,000 shares to its account. In a trade valued at $632,250, the Director bought Transmedics Group Inc shares for $126.45 each.
As published in a research note from JP Morgan on December 17, 2024, Transmedics Group Inc [TMDX] has been rated down from an Overweight to a Neutral and the price target has been revised to $75 from $116. Analysts at Needham downgraded the stock from ‘”a Buy”‘ to ‘”a Hold”‘ outlook in a report released in late November. As of October 29, 2024, Oppenheimer has reiterated its “an Outperform” rating for TMDX. Earlier on October 29, 2024, Needham resumed its rating. Their recommendation was “a Buy” for TMDX stock.
Analyzing TMDX Stock Performance
On last trading session,, Transmedics Group Inc [NASDAQ: TMDX] plunged -1.29% to $124.78. The stock’s lowest price that day was $123.795, but it reached a high of $127.97 in the same session. During the last five days, there has been a drop of approximately -2.28%. Over the course of the year, Transmedics Group Inc shares have dropped approximately -16.37%. Shares of the company reached a 52-week high of $145.50 on 06/16/25 and a 52-week low of $55.00 on 01/21/25.
Support And Resistance Levels for Transmedics Group Inc (TMDX)
According to the 24-hour chart, there is a support level at 123.06, which, if violated, would cause prices to drop to 121.34. In the upper region, resistance lies at 127.24. The next price resistance is at 129.69. RSI (Relative Strength Index) is 45.79 on the 14-day chart, showing neutral technical sentiment.
Is Transmedics Group Inc subject to short interest?
Stocks of Transmedics Group Inc saw a sharp steep in short interest on 2025-06-13 dropping by -0.24 million shares to 7.86 million. Data from Yahoo Finance shows that the short interest on 2025-05-15 was 8.1 million shares. A decline of -3.1% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 9.46 of the overall float, the days-to-cover ratio (short ratio) decline to 9.46.
Which companies own the most shares of Transmedics Group Inc (TMDX)?
In terms of Transmedics Group Inc share price expectations, FactSet research, analysts set an average price target of 114.5 in the next 12 months, down nearly -9.42% from the previous closing price of $126.41. Analysts anticipate Transmedics Group Inc stock to reach 151 by 2025, with the lowest price target being 45. In spite of this, 7 analysts ranked Transmedics Group Inc stock as Buy at the end of 2025. On September 24, 2024, Robert W. Baird assigned a price target of “an Outperform” to the stock and initiated coverage with a $200.
